InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
2
T+90 hit rate
67%
T+90 mean return
+10.6%
Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the detailed record of transactions filed by Moore Michael, President. Director active across 1 company, notably Viemed Healthcare, INC.. Cumulatively, 19 disclosures have been recorded. Split: 0 buy · 2 sells. Total volume traded: €572k. History available since 14 August 2023. The latest transaction was disclosed on 18 March 2026 (Cession). Regulator: SEC (Form 4). The full history is free.
Declarations19 total
31,570 shares@ US$9.42Common SharesSEC:0001781905-26-000011:0
34,214 sharesCommon SharesSEC:0001781905-26-000004:0
50,090 shares@ US$7.33Common SharesSEC:0001781905-25-000006:0
8,948 shares@ US$8.280.020% mcap50.0% of flowCommon SharesSEC:0001781905-25-000005:0
3,486 shares@ US$1.813.0% of flowCommon SharesSEC:0001729149-25-000109:0
26,843 sharesCommon SharesSEC:0001729149-25-000039:0
18,979 sharesCommon SharesSEC:0001729149-25-000030:0
26,939 sharesCommon SharesSEC:0001729149-25-000016:0
3,251 sharesCommon SharesSEC:0001729149-24-000141:0
9,223 shares@ US$7.3925.6% of flowCommon SharesSEC:0001729149-24-000054:0
5,761 shares@ US$7.6216.5% of flowCommon SharesSEC:0001729149-24-000056:0
18,979 sharesCommon SharesSEC:0001729149-24-000024:0
6,735 sharesCommon SharesSEC:0001729149-24-000013:0
1,722,614 shares0Common SharesSEC:0001729149-23-000119:0
3,130 sharesCommon SharesSEC:0001729149-23-000082:0
9,490 sharesCommon SharesSEC:0001729149-23-000029:0
9,490 sharesCommon SharesSEC:0001729149-23-000016:0
3,852 sharesCommon SharesSEC:0001729149-22-000052:0
58,088 sharesCommon SharesSEC:0001729149-21-000092:0
19 of 19 declarations
About Moore Michael
Michael Moore is the President of Viemed Healthcare, Inc. He leads the company with a strategic vision, focusing on growth and enhancing healthcare services. His experience in the health sector is essential for developing innovative solutions.
